Literature DB >> 19394765

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.

Matthew N Hill1, Gregory E Miller, Erica J Carrier, Boris B Gorzalka, Cecilia J Hillard.   

Abstract

Central endocannabinoid signaling is known to be responsive to stressful stimuli; however, there is no research to date characterizing the effects of stress on peripheral endocannabinoid content. The current study examined serum content of the endocannabinoid ligands N-arachidonylethanolamide (anandamide; AEA) and 2-arachidonoylglycerol (2-AG), and the non-cannabinoid N-acyl ethanolamine (NAE) molecules palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) under basal conditions, immediately following the Trier Social Stress Test (TSST), and 30 min thereafter, in 15 medication-free women diagnosed with major depression, and 15 healthy matched controls. Basal serum concentrations of AEA and 2-AG, but not PEA or OEA, were significantly reduced in women with major depression relative to matched controls, indicating a deficit in peripheral endocannabinoid activity. Immediately following the TSST, serum 2-AG concentrations were increased compared to baseline; serum AEA concentration was unchanged at this time point. Serum concentrations of PEA and OEA were significantly lower than baseline 30 min following the cessation of the TSST. The magnitude of these responses did not differ between depressed and control subjects. These are the first data to demonstrate that the peripheral endocannabinoid/NAE system is responsive to exposure to stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394765      PMCID: PMC2716432          DOI: 10.1016/j.psyneuen.2009.03.013

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  24 in total

Review 1.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

Review 2.  Endocannabinoids and the haematological system.

Authors:  M D Randall
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

Review 3.  Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.

Authors:  Boris B Gorzalka; Matthew N Hill; Cecilia J Hillard
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

Review 4.  Endogenous cannabinoids: structure and metabolism.

Authors:  T Bisogno
Journal:  J Neuroendocrinol       Date:  2008-05       Impact factor: 3.627

Review 5.  Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.

Authors:  I Matias; T Bisogno; V Di Marzo
Journal:  Int J Obes (Lond)       Date:  2006-04       Impact factor: 5.095

Review 6.  Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2006-10-27       Impact factor: 7.217

Review 7.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

Authors:  Robin Christensen; Pernelle Kruse Kristensen; Else Marie Bartels; Henning Bliddal; Arne Astrup
Journal:  Lancet       Date:  2007-11-17       Impact factor: 79.321

8.  Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells.

Authors:  I Matias; M-P Gonthier; S Petrosino; L Docimo; R Capasso; L Hoareau; P Monteleone; R Roche; A A Izzo; V Di Marzo
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

9.  Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2008-01-27       Impact factor: 5.157

10.  Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report.

Authors:  M N Hill; G E Miller; W-S V Ho; B B Gorzalka; C J Hillard
Journal:  Pharmacopsychiatry       Date:  2008-03       Impact factor: 5.788

View more
  104 in total

1.  Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

Authors:  R J Newsom; C Osterlund; C V Masini; H E Day; R L Spencer; S Campeau
Journal:  Neuroscience       Date:  2011-11-28       Impact factor: 3.590

2.  Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.

Authors:  Matthew N Hill; Cecilia J Hillard; Bruce S McEwen
Journal:  Cereb Cortex       Date:  2011-01-24       Impact factor: 5.357

Review 3.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

Review 4.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

Review 5.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

6.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

Review 7.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

8.  Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

Authors:  Gaurav Bedse; Nolan D Hartley; Emily Neale; Andrew D Gaulden; Toni A Patrick; Philip J Kingsley; Md Jashim Uddin; Niels Plath; Lawrence J Marnett; Sachin Patel
Journal:  Biol Psychiatry       Date:  2017-03-15       Impact factor: 13.382

Review 9.  Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids.

Authors:  Matthew N Hill; Bruce S McEwen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-10       Impact factor: 5.067

10.  Motion sickness, stress and the endocannabinoid system.

Authors:  Alexander Choukèr; Ines Kaufmann; Simone Kreth; Daniela Hauer; Matthias Feuerecker; Detlef Thieme; Michael Vogeser; Manfred Thiel; Gustav Schelling
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.